. 2015 Oct 13;6(35):38296–38307. doi: 10.18632/oncotarget.5699

Table 1. Patient Demographics and Clinical Characteristics.

Number of patients (tertile of SUVmax-T, SUVmax-N and EBV DNA, n = 874)
Characteristic	SUVmax-T			P	SUVmax-N			P	EBV DNA, copies/mL			P
Characteristic	<10.7	10.7–16.1	≥16.1	P	<5.7	5.7–12.3	≥12.3	P	<629	629–9,820	≥9,820	P
Age, years
Median	48	46	48		46	48	47		46	47	48
Sex				0.527				0.380				0.894
Female	63	72	61		61	74	61		64	64	68
Male	229	220	229		232	220	226		227	228	223
Histology, WHO type				0.873				0.019				0.318
II	8	7	9		2	13	9		5	11	8
III	284	285	281		291	281	278		286	281	283
Clinical stage				0.242				<0.001				<0.001
III	196	178	179		225	179	149		235	190	128
IVa-b	96	114	111		68	115	138		56	102	163
Tumor stage				<0.001				0.009				<0.001
T1	19	6	5		8	8	14		13	6	11
T2	55	29	5		20	39	30		20	33	36
T3	167	177	189		203	169	161		214	177	142
T4	51	80	91		62	78	82		44	76	102
Node stage				0.192				<0.001				<0.001
N0	34	41	33		94	11	3		60	33	15
N1	84	96	113		124	102	67		134	103	56
N2	124	112	107		65	133	145		83	127	133
N3	50	43	37		10	48	72		14	29	87
Treatment				0.512				<0.001				<0.001
RT	17	23	16		26	16	14		27	18	11
CCRT	103	84	93		125	84	71		133	93	54
NACT+CCRT	164	180	176		133	190	197		130	171	219
CCRT+AC	8	5	5		9	4	5		1	10	7
Radiotherapy technique				0.525				0.823				0.168
2DRT/3DCRT	73	70	81		72	75	77		70	68	86
IMRT	219	222	209		221	219	210		221	224	205
VCA-IgA				0.210				0.020				<0.001
<1:80	84	89	70		99	73	71		108	82	53
≥1:80	208	203	220		194	221	216		183	210	238
EA-IgA				0.156				<0.001				<0.001
<1:10	126	129	107		150	102	110		153	119	90
≥1:10	166	163	183		143	192	177		138	173	201
Smoking				0.302				0.132				0.09
No	170	188	180		191	183	164		194	172	172
Yes	122	104	110		102	111	123		97	120	119
Family history of NPC				0.855				0.876				0.102
No	258	262	257		261	263	253		266	261	250
Yes	34	30	33		32	31	34		25	31	41

Abbreviations: 2DRT = two-dimensional radiotherapy; 3DCRT = three-dimensional conformal radiotherapy; IMRT = intensity-modulated radiotherapy; VCA = viral capsid antigen; EA = early antigen; NPC = nasopharyngeal carcinoma follow-up; RT = radiation alone; CCRT = concurrent chemoradiotherapy; NACT + CCRT = neoadjuvant chemotherapy + concurrent chemoradiotherapy; CCRT + AC =concurrent chemoradiotherapy + adjuvant chemotherapy